Roche acquires antibody research co., THP, for $56.5M
Roche has acquired Therapeutic Human Polyclonals, a private company based in Germany and Mountain View, Ca. that focuses on antibody research, for $56.5 million.
See the statement here.
Roche plans to integrate THP into the Roche Pharma Center of Excellence for Protein Research in Penzberg, Germany.
Next Story: The dirt on Amazon, Steve Jobs, Topix, Fatdoor, MySpace, VC tax and more
Previous Story: Chinks in the stem-cell monopoly
